WeWork India Reports 80 Profit Surge in Q4 Revenue Climbs to Rs 715 Crore Zevra Therapeutics ZVRA Climbs 127 Resistance at 1085 in Focus 20260520 CLGN Q4 2025 Earnings Miss on EPS as PreRevenue Biotech Advances Pipeline uCloudlink UCL Stock Outlook 606 Gain Signals More Upside 20260521 SNYR Q1 2026 Earnings Stock Rises Despite Massive EPS Miss Amid Operational Challenges HMR Q4 2025 Earnings Heavy EPS Miss Despite Stock Surge Fate Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Amid Continued Pipeline Development ELAN Q1 2026 Earnings EPS Surprise Drives Positive Reaction BioTechne TECH Q1 2026 Earnings EPS Falls Short of Estimates but Stock Rises PINS Q1 2026 Earnings EPS Beat Drives Modest Stock Gains